GE Healthcare
Introducing Discovery MI
DISCOVERY MI
Introducing Discovery MI
Introducing Discovery MI
MEANINGFUL INSIGHTS.
FROM YOUR PATIENT
TO EVERY PATIENT.
Meet DiscoveryTM MI. A PET/CT system conceptualized with We understand these are the types of outcomes you want to
lofty goals, equal only to your own. It was created to help achieve. Discovery MI was engineered to help you get there.
you diagnose and stage disease earlier and better guide By delivering what you need for meaningful insights, we look
your treatment strategies. It was designed with the hope forward to your next true discovery - something we all need.
you can conduct more compelling research more often with
more novel, faster decaying tracers; permitting you to push the
boundaries of PET. And it was built with capabilities aimed
to more economically support increased patient volumes so
your facility doesn’t need to sacrifice advanced clinical work
to accelerate its research initiatives.
Optical cover and
EMC shielding
Light-tight packaging
reducing outside noise
ESR wrapped
crystal block
Optimizes light collection
improving sensitivity and
resolution
SiPM array with ASIC
Excellent timing and energy
resolutions
Digital Compton Recovery
with no resolution trade-off
High thermal
conductive pads
Extracts heat from the
detector improving stability
Mechanical support
for positioning and
alignment
Introducing Discovery MI
Technology
ENGINEERED FOR A BRILLIANT INTRODUCTION
TO ALL THAT DISCOVERY MI
PRECISION CAN DO
2x Up to 2x improvement in
volumetric resolution1
Our vision for the future of PET is completely digital. A
digital experience is what will connect all the important
technologies, data, insights and people together to make 50 %
REDUCTION
Half the time, or half the dose4
PET an indispensable tool.
Highest NEMA sensitivity of
The LightBurst Digital Detector combines a small lutetium- any TOF PET/CT system
based scintillator crystal array with a Silicon Photomultiplier
(SiPM) bloc design for high NEMA sensitivity of 13.5 cps/kBq
Significantly better small
and a large 20 cm extended axial FOV. It delivers significant
lesion detectability1
improvements over TOF-analog technology in scan times,
required dose levels and small lesion detectability1. And
Discovery MI is the only PET/CT system that brings together Highest NECR5 of any TOF
the sensitivity of digital detection with the most innovative PET/CT system
reconstruction technology available, the combination of
Time-of-Flight and Q.Clear. Up to 82 percent reduction
82 %
REDUCTION
in CT dose with ASiR-V, at
Discovery MI includes diagnostic CT innovations from our the same image quality2,3
RevolutionTM EVO. It combines the Clarity Imaging System with
the speed of the PerformixTM 40 Plus tube with our proprietary 100 percent better spatial
HiLight CT detector to deliver up to a 2x increase in spatial 100 % resolution, with no increase
resolution2. Our innovative ASiR-VTM iterative reconstruction INCREASE
in image noise with ASiR-V2
method comes standard to reduce CT dose2,3. And Smart MAR
virtually eliminates streaks and shadows from metal artifacts.
Introducing Discovery MI
Quantitation
ACCURATE RESULTS QUANTITATIVE SUV YOU AND
YOUR PATIENTS CAN TRUST
START WITH THE
LETTER “Q” Grow patient volumes as referring
physicians value the accurate,
reproducible results and diagnostic
confidence you deliver
Quantitation helped establish PET/CT as a valuable clinical More accurately assess treatment
tool. It provided an important starting point to find and follow response to guide your treatment
planning decisions with more
disease throughout the course of treatment, but it was limited
accurate SUVs
by the technologies used to produce it. Now, consistent,
accurate SUV measurements are possible with Q.SUV. The ‘Q’ Improve communication with
is important. It signifies the SUV measurement was produced improved quantitation
exclusively from our innovative PET image reconstruction
technology, Q.Clear, which delivers not only up to a 2x
improvement in PET quantitation accuracy (SUVmean ), but also
up to a 2x improvement in image quality (SNR). For this reason,
Q.Clear is a critical component of Discovery MI.
Q.SUV is more than a starting point for clinical decisions.
Because it is more accurate and consistent than conventional
methods, it becomes more than a number, it becomes a tool
for communication. As a result, it sharpens communication
between radiologists, oncologists and patients. Be sure
your SUV starts with a ‘Q’.
Capability
IMPACT ONE LIFE AT
A TIME WHILE WORKING
TO CHANGE EVERY LIFE
FOR THE BETTER
Your work is multifaceted. Not only do you work every day to
impact the lives of your patients for the better, you are looking CLINICAL WORK THAT EXCELS
for insights that will have a greater impact on the lives of every
BEYOND WHAT YOU THOUGHT
patient. You may be correcting the course of treatment for a
cancer patient one day and looking for a new clinical indication WAS POSSIBLE
for a high count-rate tracer the next. We understand. It’s why,
after collaborating with leading clinicians and institutions
Continue your efforts to diagnose
across the globe, we designed Discovery MI to give you the and stage disease earlier with
flexibility to balance the quest for true discoveries with great technology that detects smaller
clinical work. lesions1
Perform advanced diagnostic scans with FDG, or pursue Increase the number of successful
groundbreaking research with faster decaying tracers. Enhance CT scans of patients with metal
implants, with Smart MAR
your clinical excellence in oncology, or expand PET’s impact
on neurology and cardiology and beyond. Discovery MI was
Expand your diagnostic service
designed with the breakthrough technology and advanced offerings
quantitative software you need to answer the simple question
of, “What if?” Enhance utilization of limited-access
tracers, such as 68Ga, with the
What if you had a PET/CT system with enhanced capability? highest NEMA sensitivity of any
TOF PET/CT system
The capability to evaluate the patients you see today and
explore your vision for what PET/CT can be tomorrow.
Provide a more comfortable patient
experience with short scan times
Introducing Discovery MI
High resolution
THE OPPORTUNITY TO whole body 18F-FDG
scan demonstrating
INFLUENCE THE FUTURE OF exceptional resolution
MEDICINE in the spine and high
image quality and lesion
conspicuity in the right
lung, enabling high
Conduct more compelling research, diagnostic confidence
such as quantitative brain studies, in your PET/CT images.
facilitated by an expanded FOV
Data acquired on an equivalent
technology - SIGNATM PET/MR.
Pursue improvement of PET/CT
practice guidelines to better
reflect capabilities in imaging
small nodules
High resolution brain
Explore PET capabilities in cardiac image demonstrating
imaging, leveraging high sensitivity clear differentiation of
and small lesion detectability1 grey and white matter,
as well as separation of
gyri and sulci, to aid in
Increase low-yield tracer capability diagnosis of neurological
with protocols that reduce dose by disorders such as
up to 50 percent without impacting epilepsy foci, dementia
image quality and small lesion and metastatic disease.
detectability1
Data acquired on an equivalent
technology - SIGNA PET/MR.
A PET/CT SYSTEM
FOR TRUE DISCOVERY
It takes a certain kind of mind to go in search of true discovery.
A thoughtful mind. A mind like your own that looks for a way
to have a lasting impact on the world around them. You, like
us, dream of helping to change patient lives for the better and
influencing the future of medicine. To push the boundaries of
medicine beyond its daily practice.
Our purpose is to provide you with the important instruments
you need. It’s why we built Discovery MI. We see it as much
more than a new imaging product. We see it as a result of our
partnership that empowers your goal of forming new pathways
to the future of medicine.
Introducing Discovery MI
1
Improved detectability as demonstrated in phantom testing.
2
In clinical practice, the use of ASiR-V may reduce CT patient dose
depending on the clinical task, patient size, anatomical location,
and clinical practice. A consultation with a radiologist and a
physicist should be made to determine the appropriate dose to
obtain diagnostic image quality for the particular clinical task.
Low Contrast Detectability (LCD), Image Noise, Spatial Resolution
and Artifact were assessed using reference factory protocols
comparing ASiR-V and FBP. The LCD measured in 0.625 mm
slices and tested for both head and body modes using the MITA
CT IQ Phantom (CCT183, The Phantom Laboratory), using model
observer method.
3
Image quality as defined by low contrast detectability.
4
Compared to Discovery PET/CT 710.
5
Up to 20 kBq/ml.
Imagination at work
Product may not be available in all countries and regions.
Full product technical specification is available upon request.
Contact a GE Healthcare Representative for more information.
Please visit www.gehealthcare.com/promotional-locations.
Data subject to change.
©2016 General Electric Company. JB42640XX
GE, the GE Monogram, Imagination at work, Discovery, Revolution, Performix, ASIR-V,
and SIGNA are trademarks of General Electric Company.
Reproduction in any form is forbidden without prior written permission from GE.
Nothing in this material should be used to diagnose or treat any disease or condition.
Readers must consult a healthcare professional.
